New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year and start trials on children from July.
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
New Delhi [India], June 5 (ANI): Customs officials seized a total of 222 iPhones of various models along with various electronic goods among other items with an overall estimated value of over Rs 2.5 crore were seized from Delhi airport's new courier terminal on Saturday, officials said.
New Delhi [India], June 4 (ANI): After US lifted embargo on the raw materials required to produce COVID-19 vaccine, Serum Institute of India (SII) CEO Adar Poonawalla credited US President Joe Biden and Externals Affairs Minister S Jaishankar for the "policy change", stating that this will h
New Delhi [India], June 4 (ANI): The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain conditions at i
New Delhi [India], June 3 (ANI): Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India.
New Delhi [India], June 3 (ANI): Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday.
New Delhi [India], June 3 (ANI): A total of 367 iPhones with an estimated market value of Rs 3.19 crore were seized at NCT by Special Investigation and Intelligence Branch (SIIB) and ACC Export Commissionerate, informed Delhi Customs on Thursday.
Lucknow (Uttar Pradesh) [India], June 1 (ANI): A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in hi
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
New Delhi [India], May 30 (ANI): The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday.
New Delhi [India], May 23 (ANI): Two days after Serum Institute of India (SII) executive director Suresh Jadhav's controversial remarks on India's vaccination drive against COVID-19, the world's largest vaccine maker completely dissociated itself from the statement and clarified that CEO